Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia; Medical School, University of Western Australia, Perth, Western Australia, Australia.
School of Medicine, University of Notre Dame, Fremantle, Western Australia, Australia.
Atherosclerosis. 2021 Feb;319:142-148. doi: 10.1016/j.atherosclerosis.2020.12.010. Epub 2020 Dec 15.
F-Sodium Fluoride Positron Emission Tomography (F-NaF PET) non-invasively detects micro-calcification activity, the earliest stage of atherosclerotic arterial calcification. We studied the association between coronary F-NaF uptake and high-risk plaque features on intra-coronary optical coherence tomography (OCT) and CT-angiography (CTCA) and the potential application to patient-level risk stratification.
Sixty-two prospectively recruited patients with acute coronary syndrome (ACS) underwent multi-vessel OCT, F-NaF PET and CTCA. The maximum tissue to background ratio (TBRmax = standardised uptake value (SUV)max/SUVbloodpool) was measured in each coronary segment on F-NaF PET scans. High-risk plaque features on OCT and CTCA were compared in matched coronary segments. The number of patients testing positive (>2SD above the normal range) for micro-calcification activity was determined.
In 62 patients (age, mean ± standard deviation (SD) = 61 ± 9 years, 85% male) the coronary segments with elevated F-NaF uptake had higher lipid arc (LA) (median [25th-75th centile]: 74° [35°-117°] versus 48° [15°-83°], p=0.021), higher prevalence of macrophages [n(%): 37 (62%) versus 89 (39%), p=0.008] and lower plaque free wall (PFW) (50° [7°-110°] versus 94° [34°-180°], p=0.027) on OCT, and a higher total plaque burden (p=0.011) and higher dense calcified plaque burden (p= 0.001) on CTCA, when compared with F-NaF negative segments. Patients grouped by increasing number of coronary lesions positive for microcalcification activity (0,1, ≥2) showed decreasing plaque free wall, increasing calcification and increasing macrophages on OCT (respectively p=0.008, p < 0.001 and p=0.028).
F-NaF uptake is associated with high-risk plaque features on OCT and CTCA in a per-segment and per-patient analysis in subjects hospitalized for ACS.
F-氟化钠正电子发射断层扫描(F-NaF PET)可无创检测动脉粥样硬化性动脉钙化的最早阶段——微钙化活性。我们研究了冠状动脉 F-NaF 摄取与冠状动脉内光学相干断层扫描(OCT)和 CT 血管造影(CTCA)的高危斑块特征之间的关系,并探讨了其在患者水平风险分层中的潜在应用。
62 名急性冠脉综合征(ACS)患者前瞻性接受多血管 OCT、F-NaF PET 和 CTCA 检查。F-NaF PET 扫描中,每个冠状动脉节段均测量最大组织与背景比(TBRmax=标准摄取值(SUV)max/SUVbloodpool)。在匹配的冠状动脉节段上比较 OCT 和 CTCA 的高危斑块特征。确定微钙化活性检测阳性(高于正常范围 2 个标准差以上)的患者数量。
在 62 名患者(年龄,平均值±标准差(SD)=61±9 岁,85%为男性)中,F-NaF 摄取升高的冠状动脉节段的脂质弧(LA)更高(中位数[25 至 75 百分位数]:74°[35°至 117°] 与 48°[15°至 83°],p=0.021),巨噬细胞的检出率更高[n(%):37(62%)与 89(39%),p=0.008],斑块无壁区(PFW)更低[50°[7°至 110°] 与 94°[34°至 180°],p=0.027],OCT 上的斑块无壁区更低,总斑块负荷更高(p=0.011),致密钙化斑块负荷更高(p=0.001),CTCA 上的斑块无壁区更高。根据冠状动脉微钙化活性阳性病变数量(0、1、≥2)分组的患者,PFW 逐渐减少,OCT 上的钙化和巨噬细胞逐渐增多(分别为 p=0.008、p<0.001 和 p=0.028)。
在因 ACS 住院的患者中,F-NaF 摄取与 OCT 和 CTCA 的高危斑块特征在节段和患者水平上相关。